Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

Published:1997-07 Issue:7 Volume:3 Page:738-743
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kang Sang-Mo,Schneider Darren B.,Lin Zhonghua,Hanahan Douglas,Dichek David A.,Stock Peter G.,Baekkeskov Steinunn

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0797-738.pdf

Reference44 articles.

1. Nagata, S. Fas and Fas ligand: A death factor and its receptor. Adv. Immunol. 57 129–144 (1994).

2. Krammer, P.H. et al. The role of APO-1-mediated apoptosis in the immune system. Immun. Rev. 142, 175–191 (1994).

3. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449–1456 (1995).

4. Nagata, S. Fas ligand and immune evasion. Nature Med. 2, 1306–1 307 (1996).

5. Fisher, G.H. et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell l81, 935–946 (1995).

Cited by 426 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protecting Allogeneic Pancreatic Islet Grafts by Engineered Veto;2024-01-07

2. FasL microgels induce immune acceptance of islet allografts in nonhuman primates;Science Advances;2022-05-13

3. The role of regulated necrosis in endocrine diseases;Nature Reviews Endocrinology;2021-06-16

4. The FasLane to ocular pathology—metalloproteinase cleavage of membrane‐bound FasL determines FasL function;Journal of Leukocyte Biology;2021-02-10

5. Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes;Methods in Molecular Biology;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3